A fast-track diagnostic pathway that includes a specific MRI marker helped cut the average time to diagnose MS by about half, per a review.

A study tied altered neurovascular coupling, which matches brain activity with blood flow, to poorer cognitive function in MS.

The FDA agreed to speed its review of a Roche drug the developer says could be the first oral high-efficacy therapy approved for two MS types.

An estimated 3.1 million people worldwide are living with MS, up from about 2.8 million in 2020, the latest update of the Atlas of MS shows.

Having MS results in columnist Desiree Lama waging a sometimes silent battle against pain, but she's learning to listen to her body's cues.

Experimental therapy kamuvudine-9 (K-9), derived from antiviral drugs, restored lost mobility and vision in a preclinical MS study.

A digital lifestyle program was linked to lasting improvements in several measures reported by multiple sclerosis patients, a study says.

A study found 55 DNA methylation regions differed in pediatric MS, with Epstein-Barr virus infection emerging as the top-ranked pathway.

Higher blood levels of a marker of nerve damage are associated with lower daily activity in people with progressive forms of MS, per a study.

Since her MS diagnosis in 2012, guest columnist Shereese Hickson has learned that thriving with the condition means redefining strength.

A high-fat diet alters the composition of gut bacteria in multiple sclerosis, which may ultimately lead to brain damage, per a mouse study.

A new study confirms that EBV infection increases thew risk of MS and shows that common herpesviruses have differing roles in the disease.

MRI study finds signs of myelin and iron loss in RRMS, but not in AQP4-positive NMOSD, using a specialized imaging technique.

Columnist Desiree Lama offers advice about how parents of adult children with MS can assist them in their journey with their disease.

Breathing problems are common in advanced MS, and patients should be screened for them as part of routine care, a study suggested.

Four molecules may be used as biomarkers for response to MSC-NP, an experimental stem cell therapy for progressive MS, a study found.

European Union regulators recommended that the infusion therapy Ocrevus be approved to treat relapsing MS in patients ages 10 and older.

Tiziana has inked a deal to support a clinical trial testing its experimental treatment foralumab in people with hard-to-treat RRMS.

Greater disability levels are associated with more severe depression among people with RRMS, according to a study in Egypt.

Medically indicated C-sections before full term pregnancy may be more frequent among patients with MS, a study suggests.

Epstein-Barr virus reactivation in immune cells may trigger disease flares in multiple sclerosis, a study suggested.

Bael fruit extract reduced inflammation and demyelination and improved motor and memory measures in a rat model of multiple sclerosis.

Changes in the gut microbiome at the time of a multiple sclerosis diagnosis may offer early clues about the disease course, per a study.

The FDA has authorized the launch of an early-stage trial testing a CAR T-cell therapy for people with hard-to-treat progressive MS.